rs61754795

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_002485.5(NBN):​c.381T>C​(p.Ala127Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00448 in 1,612,660 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0027 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0047 ( 29 hom. )

Consequence

NBN
NM_002485.5 synonymous

Scores

3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:21O:1

Conservation

PhyloP100: 1.43

Publications

7 publications found
Variant links:
Genes affected
NBN (HGNC:7652): (nibrin) Mutations in this gene are associated with Nijmegen breakage syndrome, an autosomal recessive chromosomal instability syndrome characterized by microcephaly, growth retardation, immunodeficiency, and cancer predisposition. The encoded protein is a member of the MRE11/RAD50 double-strand break repair complex which consists of 5 proteins. This gene product is thought to be involved in DNA double-strand break repair and DNA damage-induced checkpoint activation. [provided by RefSeq, Jul 2008]
NBN Gene-Disease associations (from GenCC):
  • Nijmegen breakage syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Myriad Women's Health, ClinGen, Orphanet
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • idiopathic aplastic anemia
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 8-89980833-A-G is Benign according to our data. Variant chr8-89980833-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 132744.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.43 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00274 (418/152320) while in subpopulation SAS AF = 0.00559 (27/4832). AF 95% confidence interval is 0.00394. There are 1 homozygotes in GnomAd4. There are 202 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 29 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002485.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NBN
NM_002485.5
MANE Select
c.381T>Cp.Ala127Ala
synonymous
Exon 4 of 16NP_002476.2
NBN
NM_001024688.3
c.135T>Cp.Ala45Ala
synonymous
Exon 5 of 17NP_001019859.1A0A0C4DG07
NBN
NM_001440379.1
c.135T>Cp.Ala45Ala
synonymous
Exon 4 of 16NP_001427308.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NBN
ENST00000265433.8
TSL:1 MANE Select
c.381T>Cp.Ala127Ala
synonymous
Exon 4 of 16ENSP00000265433.4O60934
NBN
ENST00000697309.1
c.381T>Cp.Ala127Ala
synonymous
Exon 4 of 15ENSP00000513244.1A0A8V8TKY5
NBN
ENST00000697293.1
c.381T>Cp.Ala127Ala
synonymous
Exon 4 of 17ENSP00000513230.1A0A8V8TM80

Frequencies

GnomAD3 genomes
AF:
0.00275
AC:
419
AN:
152202
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00130
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00294
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00558
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00413
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00317
AC:
797
AN:
251186
AF XY:
0.00368
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.00153
Gnomad ASJ exome
AF:
0.000298
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000884
Gnomad NFE exome
AF:
0.00395
Gnomad OTH exome
AF:
0.00261
GnomAD4 exome
AF:
0.00466
AC:
6811
AN:
1460340
Hom.:
29
Cov.:
31
AF XY:
0.00474
AC XY:
3443
AN XY:
726602
show subpopulations
African (AFR)
AF:
0.000658
AC:
22
AN:
33436
American (AMR)
AF:
0.00201
AC:
90
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.000268
AC:
7
AN:
26122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39612
South Asian (SAS)
AF:
0.00649
AC:
560
AN:
86232
European-Finnish (FIN)
AF:
0.000958
AC:
51
AN:
53236
Middle Eastern (MID)
AF:
0.00226
AC:
13
AN:
5758
European-Non Finnish (NFE)
AF:
0.00524
AC:
5817
AN:
1110866
Other (OTH)
AF:
0.00416
AC:
251
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
337
674
1010
1347
1684
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
248
496
744
992
1240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00274
AC:
418
AN:
152320
Hom.:
1
Cov.:
32
AF XY:
0.00271
AC XY:
202
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.00130
AC:
54
AN:
41570
American (AMR)
AF:
0.00294
AC:
45
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00559
AC:
27
AN:
4832
European-Finnish (FIN)
AF:
0.000565
AC:
6
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00413
AC:
281
AN:
68026
Other (OTH)
AF:
0.00237
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
22
43
65
86
108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00378
Hom.:
0
Bravo
AF:
0.00266
Asia WGS
AF:
0.00116
AC:
4
AN:
3474
EpiCase
AF:
0.00354
EpiControl
AF:
0.00385

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
5
not provided (6)
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
-
4
Microcephaly, normal intelligence and immunodeficiency (4)
-
-
1
Acute lymphoid leukemia (1)
-
-
1
Aplastic anemia;C0023449:Acute lymphoid leukemia;C0398791:Microcephaly, normal intelligence and immunodeficiency (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
12
DANN
Benign
0.77
PhyloP100
1.4
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs61754795; hg19: chr8-90993061; COSMIC: COSV104545489; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.